|
Australasian Biotechnology (backfiles)
AusBiotech
ISSN: 1036-7128
Vol. 11, Num. 6, 2001, pp. 5
|
Australasian Biotechnology, Vol. 11 No. 6, 2001, pp. 5
FROM THE EDITOR - Honesty and openness - the key to a biotech
future
Dr Martin Playne, Editor
Code Number: au01070
It
is traditional at this time of year to ponder a little on the future, as well
as to review the happenings of the last twelve months - the achievements, success
stories, the disappointments, and matters left unfinished. To me, it is imperative
that emerging biotech companies not only learn how to commercialise and export
their products highly effectively, but maintain top standards of honesty and
openness at all times.
The biotech industry at large will
continue to face opposition to cloning,
therapeutic or reproductive; to privacy
of the DNA fingerprint; and to GM
foods from a cross section of the
community. Most of this opposition
is quite unfounded. Often, it is
misdirected, and results from
misinformation, innuendo, and a lack
of understanding of the science.
Frequently, biotech is being blamed
for issues of the globe, such as the
global economy, the legal and patent
system, world population, and religious
views, and not with issues concerning
the science and technology of
biotechnology. The pace of technical
development has become too fast for
many. It is important for the biotech
community to understand these
concerns and what lies behind them.
We should not just shut our doors
and label opponents as stirrers and
malcontents. We have to make a big
effort to provide unbiased information
at a level which can be understood
by the lay person with no scientific
training (even at school level). We have
to take every opportunity to do this,
even though we are busy with company
work. We must not duck and weave
to difficult questions; we must not hide
behind a facade of its all too difficult
for you to understand, but trust us.
There is nothing wrong with being
honest and open, and telling people
that we do not always know the answer.
The Australian biotech industry has a
pretty good record to date, as have
the regulatory bodies in Australia. The
Gene Technology Act is just coming into
force, and we will also have a Privacy
Act in place by years end. We have
a new Director of the Office of the
Gene Technology Regulator (Dr Sue
Meek), and we know that she is a very
sound, fair, and balanced person who
should fulfil that potentially difficult
role well. The Genetic Manipulation
Advisory Committee (GMAC) now
largely superseded by the new OTGR,
has, for many years, under the unique
leadership of Professor Nancy Millis,
given Australia very sound rules on
genetic modification, which were copied
by many overseas countries. The very
sound base set by GMAC, I am sure, has
resulted in Australians being relatively
open to the new biotechnologies.
This journal, and indeed the
association, has provided for 16 years
balanced, unbiased information on
biotechnology. Our series of
educational leaflets has been
exceptionally well received, not only
in Australian schools, but overseas in
many training institutions. There is still
a strong need for such information, set
in the Australian context. I hope our
journal can continue to provide a wide
variety of opinion, and balanced articles
on biotechnology in the years ahead.
It is important that it does this well,
as well as being the official journal of
our association, AusBiotech. There is
potentially a conflict of interest here
- providing promotion of a biotech
industry and its member companies on
the one hand, and unbiased balanced
information on biotechnology on the
other. We will strive to achieve this. It
would be pleasing to me for this journal
to be available on newsagents stands. It
certainly would widen the exposure of
the association, but could strengthen its
role as an educational tool.
I wish you a very happy Christmas and
New Year, and I thank all those involved
in the production of the journal for
their wonderful efforts during a year
of much change for the association.
We thank you, the readers, for your
contributions and commentaries during
the year. We look forward to working
with you during 2002.
By Martin Playne, Editor
Copyright 2001 - AusBiotech
|